Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Bruce Edward Hansen, a director at Verisk Analytics, Inc., recently sold a significant block of company stock. This transaction occurred after he acquired the shares through the exercise of existing options. The sale takes place against a backdrop of several corporate developments for Verisk, including the launch of new AI connectors for its Claude…
The Chief Financial Officer of Kingsway Corp, Kent A. Hansen, recently purchased a block of common stock shares. This transaction occurred while the stock was trading near its 52-week low. Separately, Kingsway reported strong first-quarter consolidated revenue growth coupled with corporate changes, including a major asset sale and leadership appoin…
The CEO of Kingsway Corp, John Taylor Maloney Fitzgerald, recently acquired shares of the company's common stock. This purchase occurred while the stock was trading near its 52-week low. Furthermore, the article details several significant financial milestones for Kingsway Financial Services, including a substantial revenue increase and the complet…
Bread Financial’s leadership recently executed a significant sale of common stock. Despite this insider activity, the company reported an improvement in its net principal loss rate for April 2026 and noted growth in its loan portfolio. Additionally, Bread Financial is undergoing capital structure changes, including the issuance of new preferred sha…
Jean Francois Formela, a director at Korro Bio, Inc. (KRRO), recently sold 2,860 shares of common stock valued at $39,897. The transaction was carried out via a Rule 10b5-1 trading plan adopted earlier this year. This sale took place against a backdrop of varied analyst recommendations for KRRO, which is developing its RNA editing platform and curr…
Director Bruno Sousa Mauad sold a total of 132,356 common shares of Aura Minerals Inc. (NASDAQ:AUGO) across two transactions in late May 2026, valued at approximately $10.24 million. This selling occurred despite the stock delivering a significant 220% return over the past year. The report also details additional derivative activity and notes that …
Insiders have recently engaged in buying activity at Goosehead Insurance (GSHD), adding to existing holdings. This activity occurs against a backdrop of robust financial performance for the first quarter of 2026, where the company notably exceeded both earnings and revenue expectations. Multiple analysts have reiterated positive outlooks and set el…
The Chief Legal Officer at TransUnion recently sold a significant amount of company stock through a pre-arranged trading plan. This insider activity is reported alongside positive operational news, including the company's first quarter 2026 earnings that surpassed analyst expectations. Furthermore, TransUnion announced a quarterly dividend and expa…
A review of SEC Form 4 filings reveals that Joshua Horowitz, a director at Kingsway Corp (KWY), recently purchased common stock worth $44,624 over two days in late May. These transactions occurred while KWY's shares were trading near their 52-week low of $9.80. The purchases were executed indirectly through the Palm Global Small Cap Master Fund LP.…
Cambrian BioPharma Inc., a significant shareholder, recently executed the sale of a portion of its stake in Sensei Biotherapeutics, Inc. This transaction occurred as Sensei's stock has seen substantial gains over the past year. Despite the divestiture, the underlying clinical progress and analyst coverage for Sensei remain key focal points.
A significant transaction was reported involving a major shareholder in Sensei Biotherapeutics, Inc. (NASDAQ:SNSE). On June 1, 2026, James Peyer, who holds a ten percent ownership stake in the company, sold shares totaling $500,542. This sale occurred while the stock had seen substantial gains, rising nearly 19% over the preceding week and trading …
Fred Faching Chang, a director and significant shareholder of Newegg Commerce, Inc. (NASDAQ:NEGG), executed two notable sales of company common stock in late May. These reported insider transactions suggest activity from an internal stakeholder amid the stock's highly volatile trading history. The total value of the shares sold across these transac…
Christopher Hatto, Vice President & Chief Accounting Officer at General Motors Co., recently sold a significant block of company common stock. This transaction occurs amid various operational challenges for General Motors, including workforce reductions, vehicle recalls, and adjustments to electric vehicle production schedules. Furthermore, the com…
Nexstar Media Group's President of Broadcasting, Andrew Alford, executed a sale of company stock in late May 2026. This insider activity occurs as the company reports robust first-quarter financial results that surpassed Wall Street forecasts. The strong performance was attributed in part to the successful integration of Tegna operations, alongside…
A senior executive at Target Corp. was reported selling a substantial amount of company stock in May 2026, despite the retailer's recent strong financial disclosures and positive analyst actions. The sale occurred while the stock had seen significant gains over the past six months. Recent quarterly reports show robust sales increases across both ph…
Paul Bigbee, Chief Accounting Officer at Cavco Industries (NASDAQ:CVCO), sold shares of the company's common stock on May 28, 2026. This insider transaction occurred against a backdrop of mixed financial signals for the company, which reported Q4 earnings per share (EPS) that beat analyst expectations but saw revenue fall short of projections.
A director at USANA Health Sciences Inc., John Turman Fleming, recently sold a portion of his company stock. This transaction occurred against a backdrop of the company reporting strong first-quarter financial results and holding its annual shareholder meeting. The reported sale details are presented alongside data indicating the current stock pric…
Vitesse Energy director Joseph S. Steinberg purchased a substantial amount of the company's common stock on May 28, 2026. This transaction occurs while the stock is trading near its 52-week low and following disappointing Q1 2026 financial results, leading to mixed signals regarding internal confidence and the company's valuation.
Hyatt Hotels Corp's Executive Vice President, Peter Sears, reported selling a total of 10,217 shares of the company’s Class A Common Stock on May 29, 2026. These sales totaled approximately $1.9 million, occurring while Hyatt shares trade near their annual high and following various analyst revisions and leadership announcements.
Director Sandra AJ Lawrence of Evergy, Inc. (NASDAQ:EVRG) executed stock sales totaling $96,215 worth of common shares across two separate transactions during the end of May. These details were documented in a Form 4 filing submitted to the Securities and Exchange Commission on June 1, 2026.The divestiture occurred over two days: on May 28, Ms. Law…
The Chief Operating Officer of GRID DYNAMICS HOLDINGS, INC., Yury Gryzlov, executed a sale of company common stock totaling $35,480. This transaction occurred while the firm reported its first-quarter 2026 financial results, which showed revenue exceeding market expectations but earnings per share (EPS) missing forecasts. Furthermore, Grid Dynamics…
The article details an insider transaction involving Mark S. Silver, Executive Vice President and Chief Legal/Risk Officer at Ryerson Holding Corp (NYSE:RYZ). Mr. Silver sold 11,174 shares totaling $311,842 in late May 2026. This activity occurs as the stock has seen a significant increase over the past year. Separately, Ryerson Holding Corp recent…
The President of Research & Development at Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), David Young, recently acquired a significant block of company stock. On May 29, 2026, Mr. Young purchased 1,786 shares of common stock for a total investment of $4,590. This transaction occurred when the per-share price was $2.57, which was slightly higher than…
Patrick Lin, Chief Business and Strategy Officer of Processa Pharmaceuticals, Inc. (PCSA), recently purchased additional common stock, an action that some analysts interpret as a reflection of internal confidence. The acquisition occurred while the company's stock was trading close to its recent low point.
Wendy Guy, Chief Administrative Officer at Processa Pharmaceuticals, Inc., recently acquired a block of shares in the company. The purchase occurred on May 29, 2026. This insider transaction is noteworthy given that the stock has experienced a significant decline over the past six months, though current analysis suggests potential undervaluation.
